Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
| The first 150 words of the full text of this article appear below. |
EDITOR
The confidential inquiry into genetic counselling by
non-geneticists (CEGEN) investigated free personal choice in consent for genetic screening, testing, or intervention in clinical records of
non-directive genetic counselling. It audited 621 pregnancies affected
by Down's syndrome in women over 34; 271 infants with neural tube
defects; 46 infants with cystic fibrosis who had a full sibling with
cystic fibrosis; 172 pregnancies affected by thalassaemia; and 212 people with multiple endocrine neoplasia type II. Adverse events
were sought when cases lacked documentation of informed choice.
Clinical records were unacceptably poor, rarely showing whether genetic
counselling had been offered or stating the reasons for accepting or
rejecting an abortion. Less than half of cases known in advance to be
at high genetic risk were referred to a clinical geneticist. Most
couples with undetected thalassaemia were British Pakistanis; their
records assumed that they would decline genetic abortion for religious
reasons, but over 70% of British Pakistanis